Home » Topics » BioWorld Science

BioWorld Science
RSS

Idorsia Pharmaceuticals patents LGALS3 inhibitors

April 29, 2022

AC-0027875, a gamma-secretase modulator for the treatment of AD

April 29, 2022

Merck & Co. presents DGAT-2 inhibitors

April 29, 2022

Dana-Farber Cancer Institute discloses new HER2 inhibitors

April 29, 2022

Vertex Pharmaceuticals patents CFTR potentiators

April 29, 2022

University of California discloses new PRMT8 inhibitors

April 29, 2022

ProfoundBio presents novel ADCs for cancer treatment

April 29, 2022

Study finds targets of T-cell response in multiple sclerosis

April 28, 2022

Allogeneic NK-cell therapy CAT-179 useful for controlling HER2-positive tumors

April 28, 2022

AT-0174 IDO/TDO dual inhibitor shows promise for treating platinum-resistant NSCLC

April 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...